Pharmafile Logo
Pharmafocus logo
Advanced Search

TB

Showing 15 posts of 19 posts found.

BATM develops molecular diagnostics test for tuberculosis

March 29, 2021
Sales and Marketing TB, testing

BATM have announced that it has developed a new method for the rapid and comprehensive diagnosis of tuberculosis (TB), which …

News
johnsonsss

Johnson & Johnson cuts price of anti-TB medicine in poorer countries

July 7, 2020
Manufacturing and Production J&J, JJ, TB

Johnson & Johnson have announced that it will cut the price of its tuberculosis drug Bedaquiline, sold under the brand …

News

FDA approve new drug for treatment-resistant TB

August 15, 2019
Research and Development FDA, TB, US, pharma, pretomanid, tuberculosis

The US FDA has approved BPaL, the TB Alliance’s treatment for drug-resistant tuberculosis (TB). The US regulator gave the go-ahead …

News

Global Fund seeks £11bn as progress slows in fight against malaria, TB and HIV

January 14, 2019
Sales and Marketing Africa, Global Fund, HIV, TB, infectious diseases, malaria, tuberculosis

The Global Fund is seeking £11 billion worth of investment in an attempt to save 16 million lives in the …

News
jj_sign_on_wall

J&J pledges to end global TB pandemic

September 25, 2018
Manufacturing and Production J&J, JJ, Johnson and Johnson, TB, access, tuberculosis

Johnson and Johnson have announced that they are launching a 10-year initiative aimed at helping to end tuberculosis, the world’s …

News
tb_bacteria

Body’s natural defence mechanism against TB discovered

May 11, 2017
Research and Development Francis Crick Institute, TB, tuberculosis

Research conducted by the Francis Crick Institute has revealed how the body protects itself from Mycobacterium tuberculosis, the bacterium responsible …

News
bayercross3

Bayer to collaborate on new treatments for tuberculosis with Universities of Dundee, Cape Town

March 8, 2016
Manufacturing and Production, Research and Development Bayer, TB, tuberculosis, university of cape town, university of dundee

The pharmaceuticals division at German-based Bayer will collaborate with the renowned medicinal chemistry and biology departments at the Universities of …

News

Europe: TB treatment ‘far below’ target

March 19, 2014
Research and Development, Sales and Marketing EU, MDR TB, TB, WHO, tuberculosis

European countries are still not getting to grips with the diagnosis and treatment of tuberculosis, according to a new report …

News
EMA image

Thyroid cancer, TB resistance drugs top EMA approvals

December 23, 2013
Sales and Marketing EMA, TB, thyroid

The European Medicines Agency has shown the green light to a new treatment for thyroid cancer and one for drug …

News

UK pledges £1 billion to fight AIDS, TB and malaria

September 24, 2013
Medical Communications, Research and Development, Sales and Marketing AIDS, TB, funding, malaria

News
Eisai image

Eisai backs disease fund

July 12, 2013
Research and Development, Sales and Marketing Eisai, Japan, TB, partnership

A leading Japanese pharma group says that the sector should see investment in fighting diseases of the developing world as …

News
GSK image

GSK signs TB vaccine agreement

October 11, 2012
Research and Development, Sales and Marketing Aeras, GSK, TB

GlaxoSmithKline Vaccines has signed a deal with US not-for-profit biotech Aeras to develop a new vaccine which will treat tuberculosis …

News

Gates urges investment in innovations for developing nations

January 25, 2012
Research and Development AIDS, Bill Gates, Global Fund, TB, malaria

Bill Gates has called on global leaders to invest in innovations that are accelerating progress against poverty, or risk a …

News

Lilly launches ‘open innovation’ drug discovery

September 28, 2011
Research and Development OIDD, TB, lilly

Lilly has launched a new open innovation platform designed to help build its pipeline and to identify new treatments for …

News
GlaxoSmithKline

GSK welcomes outside researchers to its ‘open lab’

June 29, 2011
Research and Development GSK, TB, academic alliance, malaria, open lab

The first scientists from outside GlaxoSmithKline have started work at the manufacturer’s ‘open lab’ for diseases of the developing world …

News

Latest content

BactiVac funds development of bacterial vaccines to prevent infections against antimicrobial resistance

September 28, 2023

Avalyn Pharma raises $175m in Series C financing for inhalation therapies

September 28, 2023

NMD Pharma begins phase 2 trial for spinal muscular atrophy treatment

September 27, 2023

Alfasigma to acquire Intercept Pharmaceuticals for $19 per share

September 27, 2023

Regeneron and Sanofi’s sBLA for Dupixent accepted by FDA for priority review

September 26, 2023